Atlas Trials

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Clinical trial NCT00777504 · UNKNOWN

Trial details

NCT number
NCT00777504
Sponsor
Radboud University Medical Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Renal Cell CarcinomaGastrointestinal Stromal Tumor
Start date
2008-10-01
Primary completion
2012-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.